Association of blaOXA-23 and bap with the persistence of Acinetobacter baumannii within a major healthcare system

Frontiers in Microbiology

Volumn 6, Issue MAR, 2015, Pages

  Luo, Ting L ^a   Rickard, Alexander H ^a   Srinivasan, Usha ^a   Kaye, Keith S ^b   Foxman, Betsy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic resistance; Bap; Biofilms; Molecular epidemiology; OXA 23; REP PCR

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BAP GENE; BIOFILM; BLAOXA 23 GENE; CONFOCAL LASER MICROSCOPY; DISEASE SURVEILLANCE; FEMALE; GENE; GENETIC MARKER; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION;

ACINETOBACTER BAUMANNII;

EID: 84927164153     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00182     Document Type: Article

References (55)

1. Bergogne-Berezin, E. (2001). The increasing role of Acinetobacter species as nosocomial pathogens. Curr. Infect. Dis. Rep. 3, 440-444. doi: 10.1007/BF03160479.
2. Bou, G., Cervero, G., Dominguez, M. A., Quereda, C., and Martinez-Beltran, J. (2000). PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem-and meropenem-resistant Acinetobacter baumannii. Clin. Microbiol. Infect. 6, 635-643. doi: 10.1046/j.1469-0691.2000.00181.x.
3. Brossard, K. A., and Campagnari, A. A. (2012). The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect. Immun. 80, 228-233. doi: 10.1128/IAI.05913-11.
4. BSAC. (2011). BSAC Methods for Antimicrobial Susceptibility Testing. Birmingham: British Society for Antimicrobial Chemotherapy.
5. Butaye, P., Michael, G. B., Schwarz, S., Barrett, T. J., Brisabois, A., and White, D. G. (2006). The clonal spread of multidrug-resistant non-typhi Salmonella serotypes. Microbes Infect. 8, 1891-1897. doi: 10.1016/j.micinf.2005.12.020.
6. CLSI. (2011). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute.
7. Coelho, J., Woodford, N., Afzal-Shah, M., and Livermore, D. (2006). Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob. Agents Chemother. 50, 756-758. doi: 10.1128/AAC.50.2.756-758.2006.
8. Coffey, B. M., and Anderson, G. G. (2014). Biofilm formation in the 96-well microtiter plate. Methods Mol. Biol. 1149, 631-641. doi: 10.1007/978-1-4939-0473-0_48.
9. Craig, W. A., Uman, S. J., Shaw, W. R., Ramgopal, V., Eagan, L. L., and Leopold, E. T. (1978). Hospital use of antimicrobial drugs. Survey at 19 hospitals and results of antimicrobial control program. Ann. Intern. Med. 89(5 Pt 2 Suppl.), 793-795. doi: 10.7326/0003-4819-89-5-793.
10. Dalla-Costa, L. M., Coelho, J. M., Souza, H. A., Castro, M. E., Stier, C. J., Bragagnolo, K. L., et al. (2003). Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J. Clin. Microbiol. 41, 3403-3406. doi: 10.1128/JCM.41.7.3403-3406.2003.
11. Doi, Y., Murray, G. L., and Peleg, A. Y. (2015). Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options. Semin. Respir. Crit. Care Med. 36, 85-98. doi: 10.1055/s-0034-1398388.
12. Donlan, R. M., and Costerton, J. W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167-193. doi: 10.1128/CMR.15.2.167-193.2002.
13. Douglass, J. P., Lloyd, S., Sullivan, J. E. D., Murad, N., Ajluni, M., and Zervos, M. (2008). Descriptive study of a novel OXA-23 carbapenemase strain of Acinetobacter baumannii in a large acute care hospital in Southeastern Michigan. Am. J. Infect. Control. 36, E15-E16. doi: 10.1016/j.ajic.2008.04.014.
14. Falagas, M. E., Koletsi, P. K., and Bliziotis, I. A. (2006). The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J. Med. Microbiol. 55(Pt 12), 1619-1629. doi: 10.1099/jmm.0.46747-0.
15. Falagas, M. E., Mourtzoukou, E. G., Polemis, M., Vatopoulos, A. C., and Greek System for Surveillance of Antimicrobial, R. (2007). Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications. Clin. Microbiol. Infect. 13, 816-819. doi: 10.1111/j.1469-0691.2007.01761.x.
16. Fishman, N. (2006). Antimicrobial stewardship. Am. J. Med. 119(6 Suppl. 1), S53-S61. discussion: S62-S70.
17. Fuchs, G., and Kroger, A. (1999). Growth and Nutrition. Stuttgart: Georg Thieme Verlag.
18. Garg, A., and Guez, G. (2011). Antimicrobial stewardship. Dent. Implantol. Update 22:54.
19. Girlich, D., Poirel, L., and Nordmann, P. (2010). First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate. Antimicrob. Agents Chemother. 54, 578-579. doi: 10.1128/AAC.00861-09.
20. Goh, H. M., Beatson, S. A., Totsika, M., Moriel, D. G., Phan, M. D., Szubert, J., et al. (2013). Molecular analysis of the Acinetobacter baumannii biofilm-associated protein. Appl. Environ. Microbiol. 79, 6535-6543. doi: 10.1128/AEM.01402-13.
21. Hall-Stoodley, L., and Stoodley, P. (2005). Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol. 13, 7-10. doi: 10.1016/j.tim.2004.11.004.
22. Huttner, A., Harbarth, S., Carlet, J., Cosgrove, S., Goossens, H., Holmes, A., et al. (2013). Antimicrobial resistance: a global view from the 2013 world healthcare-associated infections forum. Antimicrob. Resist. Infect. Control 2, 31. doi: 10.1186/2047-2994-2-31.
23. Jeon, B. C., Jeong, S. H., Bae, I. K., Kwon, S. B., Lee, K., Young, D., et al. (2005). Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea. J. Clin. Microbiol. 43, 2241-2245. doi: 10.1128/JCM.43.5.2241-2245.2005.
24. Kempf, M., Eveillard, M., Deshayes, C., Ghamrawi, S., Lefrancois, C., Georgeault, S., et al. (2012). Cell surface properties of two differently virulent strains of Acinetobacter baumannii isolated from a patient. Can. J. Microbiol. 58, 311-317. doi: 10.1139/w11-131.
25. Koeleman, J. G., van der Bijl, M. W., Stoof, J., Vandenbroucke-Grauls, C. M., and Savelkoul, P. H. (2001). Antibiotic resistance is a major risk factor for epidemic behavior of Acinetobacter baumannii. Infect. Control Hosp. Epidemiol. 22, 284-288. doi: 10.1086/501901.
26. Lee, C., and Lim, H. (1980). New device for continuously monitoring the optical density of concentrated microbial cultures. Biotechnol. Bioeng. 22, 4. doi: 10.1002/bit.260220312.
27. Loehfelm, T. W., Luke, N. R., and Campagnari, A. A. (2008). Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J. Bacteriol. 190, 1036-1044. doi: 10.1128/JB.01416-07.
28. Luo, L., Jiang, X., Wu, Q., Wei, L., Li, J., and Ying, C. (2011). Efflux pump overexpression in conjunction with alternation of outer membrane protein may induce Acinetobacter baumannii resistant to imipenem. Chemotherapy 57, 77-84. doi: 10.1159/000323620.
29. Manchanda, V., Sanchaita, S., and Singh, N. (2010). Multidrug resistant acinetobacter. J. Glob. Infect. Dis. 2, 291-304. doi: 10.4103/0974-777X.68538.
30. Maragakis, L. L., and Perl, T. M. (2008). Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46, 1254-1263. doi: 10.1086/529198.
31. Marchaim, D., Navon-Venezia, S., Schwartz, D., Tarabeia, J., Fefer, I., Schwaber, M. J., et al. (2007). Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J. Clin. Microbiol. 45, 1551-1555. doi: 10.1128/JCM.02424-06.
32. Martins, A. F., Kuchenbecker, R., Sukiennik, T., Boff, R., Reiter, K. C., Lutz, L., et al. (2009). Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil. Infection 37, 474-476. doi: 10.1007/s15010-009-9003-9.
33. Martins, N., Picao, R. C., Adams-Sapper, S., Riley, L. W., and Moreira, B. M. (2015). Association of class 1 and 2 integrons with multidrug-resistant Acinetobacter baumannii international clones and Acinetobacter nosocomialis isolates. Antimicrob. Agents Chemother. 59, 698-701. doi: 10.1128/AAC.02415-14.
34. Nait Chabane, Y., Mlouka, M. B., Alexandre, S., Nicol, M., Marti, S., Pestel-Caron, M., et al. (2014). Virstatin inhibits biofilm formation and motility of Acinetobacter baumannii. BMC Microbiol. 14:62. doi: 10.1186/1471-2180-14-62.
35. Niu, C., Clemmer, K. M., Bonomo, R. A., and Rather, P. N. (2008). Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii. J. Bacteriol. 190, 3386-3392. doi: 10.1128/JB.01929-07.
36. O'Toole, G. A. (2011). Microtiter dish biofilm formation assay. J. Vis. Exp. 47:e2437. doi: 10.3791/2437.
37. O'Toole, G. A., and Kolter, R. (1998). Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28, 449-461. doi: 10.1046/j.1365-2958.1998.00797.x.
38. Opazo, A., Dominguez, M., Bello, H., Amyes, S. G., and Gonzalez-Rocha, G. (2012). OXA-type carbapenemases in Acinetobacter baumannii in South America. J. Infect. Dev. Ctries. 6, 311-316. doi: 10.3855/jidc.2310.
39. Pavel, A. B., and Vasile, C. I. (2012). PyElph-a software tool for gel images analysis and phylogenetics. BMC Bioinformatics 13:9. doi: 10.1186/1471-2105-13-9.
40. Peleg, A. Y., Seifert, H., and Paterson, D. L. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538-582. doi: 10.1128/CMR.00058-07.
41. Piddock, L. J. (2006). Multidrug-resistance efflux pumps-not just for resistance. Nat. Rev. Microbiol. 4, 629-636. doi: 10.1038/nrmicro1464.
42. Pour, N. K., Dusane, D. H., Dhakephalkar, P. K., Zamin, F. R., Zinjarde, S. S., and Chopade, B. A. (2011). Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters. FEMS Immunol. Med. Microbiol. 62, 328-338. doi: 10.1111/j.1574-695X.2011.00818.x.
43. Ralser, M., Querfurth, R., Warnatz, H. J., Lehrach, H., Yaspo, M. L., and Krobitsch, S. (2006). An efficient and economic enhancer mix for PCR. Biochem. Biophys. Res. Commun. 347, 747-751. doi: 10.1016/j.bbrc.2006.06.151.
44. Rao, D., Arvanitidou, E., Du-Thumm, L., and Rickard, A. H. (2011). Efficacy of an alcohol-free CPC-containing mouthwash against oral multispecies biofilms. J. Clin. Dent. 22, 187-194.
45. Rao, R. S., Karthika, R. U., Singh, S. P., Shashikala, P., Kanungo, R., Jayachandran, S., et al. (2008). Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii. Indian J. Med. Microbiol. 26, 333-337. doi: 10.4103/0255-0857.43566.
46. Reasoner, D. J., and Geldreich, E. E. (1985). A new medium for the enumeration and subculture of bacteria from potable water. Appl. Environ. Microbiol. 49, 1-7.
47. Reddy, T., Chopra, T., Marchaim, D., Pogue, J. M., Alangaden, G., Salimnia, H., et al. (2010). Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system. Antimicrob. Agents Chemother. 54, 2235-2238. doi: 10.1128/AAC.01665-09.
48. Rodriguez-Bano, J., Marti, S., Soto, S., Fernandez-Cuenca, F., Cisneros, J. M., Pachon, J., et al. (2008). Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin. Microbiol. Infect. 14, 276-278. doi: 10.1111/j.1469-0691.2007.01916.x.
49. Samuelsen, O., Toleman, M. A., Hasseltvedt, V., Fuursted, K., Leegaard, T. M., Walsh, T. R., et al. (2011). Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance. Clin. Microbiol. Infect. 17, 1811-1816. doi: 10.1111/j.1469-0691.2011.03532.x.
50. Simões, M., Simões, L. C., and Vieira, M. J. (2010). A review of current and emergent biofilm control strategies. LWT-Food Sci. Technol. 43, 10. doi: 10.1016/j.lwt.2009.12.008.
51. Smith, C. A., Antunes, N. T., Stewart, N. K., Toth, M., Kumarasiri, M., Chang, M., et al. (2013). Structural basis for carbapenemase activity of the OXA-23 beta-lactamase from Acinetobacter baumannii. Chem. Biol. 20, 1107-1115. doi: 10.1016/j.chembiol.2013.07.015.
52. Snelling, A. M., Gerner-Smidt, P., Hawkey, P. M., Heritage, J., Parnell, P., Porter, C., et al. (1996). Validation of use of whole-cell repetitive extragenic palindromic sequence-based PCR (REP-PCR) for typing strains belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex and application of the method to the investigation of a hospital outbreak. J. Clin. Microbiol. 34, 1193-1202.
53. Thallinger, B., Prasetyo, E. N., Nyanhongo, G. S., and Guebitz, G. M. (2013). Antimicrobial enzymes: an emerging strategy to fight microbes and microbial biofilms. Biotechnol. J. 8, 97-109. doi: 10.1002/biot.201200313.
54. Van Houdt, R., Aertsen, A., Jansen, A., Quintana, A. L., and Michiels, C. W. (2004). Biofilm formation and cell-to-cell signalling in Gram-negative bacteria isolated from a food processing environment. J. Appl. Microbiol. 96, 177-184. doi: 10.1046/j.1365-2672.2003.02131.x.
55. Vila, J., Marcos, M. A., and Jimenez de Anta, M. T. (1996). A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J. Med. Microbiol. 44, 482-489. doi: 10.1099/00222615-44-6-482.